ArticleF1000Research2017
The future of metabolomics in ELIXIR.
Article in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Capillary Electrophoresis-Mass Spectrometry at Trial by Metabo-Ring: Effective Electrophoretic Mobility for Reproducible and Robust Compound Annotation.Analytical chemistry · 2020Trial
- Review
- Fostering and sustaining collaborative innovation: Insights from ELIXIR Europe's life science Communities.F1000Research · 2025Article
- Emerging technologies and their impact on regulatory science.Experimental biology and medicine (Maywood, N.J.) · 2022Review
- ELIXIR and Toxicology: a community in development.F1000Research · 2021Article
- The ChemicalToolbox: reproducible, user-friendly cheminformatics analysis on the Galaxy platform.Journal of cheminformatics · 2020Article
- The nPYc-Toolbox, a Python module for the pre-processing, quality-control and analysis of metabolic profiling datasets.Bioinformatics (Oxford, England) · 2019Article
- Metabolic Fingerprint of Chronic Obstructive Lung Diseases: A New Diagnostic Perspective.Metabolites · 2019Article
- Experimental Design and Sample Preparation in Forest Tree Metabolomics.Metabolites · 2019Review
- PhenoMeNal: processing and analysis of metabolomics data in the cloud.GigaScience · 2019Article
- Beyond genomics: understanding exposotypes through metabolomics.Human genomics · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors.
Funding
Abstract
Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the "Future of metabolomics in ELIXIR" was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.